Japan's BioWa extends partnership with Cantargia

Cantargia AB and BioWa Inc. have signed an extension of the license agreement around the BioWa proprietary POTELLIGENTTe...

August 27, 2019 | Tuesday | News
Atonarp Inc. completes $33M series C funding round

Atonarp, a Japan headquartered hi-tech molecular diagnostics company, has announced that it has raised $33 million&...

August 26, 2019 | Monday | News
Luye Pharma's anti-depression drug to start clinical trials in Japan

Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hy...

August 22, 2019 | Thursday | News
GSK submits first regulatory application for daprodustat in Japan

GSK has announced the submission of a Japanese New Drug Application (JNDA) to the Ministry of Health, Labour and Welfare...

August 23, 2019 | Friday | News
Takeda files NDA for subcutaneous formulation of Vedolizumab

Takeda Pharmaceutical Company Limited has submitted a New Drug Application (NDA) to the Ministry of Health, Labour and W...

August 21, 2019 | Wednesday | News
Japanese scientists develop 3D printed prosthetic hand

The Biological Systems Engineering Lab at Hiroshima University, Japan has developed a new 3D printed prosthetic hand com...

August 16, 2019 | Friday | News
Shimadzu receives FDA clearance for FLUOROspeed X1

Shimadzu Medical Systems, a subsidiary of Shimadzu Corporation Japan, is proud to announce that they have received FDA 5...

August 14, 2019 | Wednesday | News
OssDsign AB files regulatory approval for OssDsign Cranial in Japan

OssDsign AB (publ), the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a ...

August 12, 2019 | Monday | News
Eisai refreshes medical skin care product Sahne

Eisai Co., Ltd. has announced that it refresh its SAHNE® CREAM (quasi-drug) which has been widely used as medic...

August 9, 2019 | Friday | News
Astellas Initiates Phase 3 Clinical Trials for Fezolinetant

Japan based Astellas Pharma Inc. has announced dosing of the first patient in the SKYLIGHT 1™ Phase 3 pivotal tria...

August 8, 2019 | Thursday | News
Pola Orbis to create unique value in dermatology

POLA Chemical Industries, Inc. Frontier Research Center (FRC) of POLA ORBIS Holdings Inc. and one of the world's top res...

August 7, 2019 | Wednesday | News
FDA approves Daiichi Sankyo's TURALIO

Daiichi Sankyo Company has announced that the U.S. Food and Drug Administration (FDA) approved TURALIO™(pexidartin...

August 5, 2019 | Monday | News
Sosei Heptares, Takeda enter into multi-target partnership

Sosei Group Corporation has announced that it has entered into a strategic multi-target partnership with Takeda Pharmace...

August 6, 2019 | Tuesday | News
Rakuten Medical to further develop its photo-immunotherapy

Rakuten Medical, Inc., a clinical-stage, global biotechnology company developing precision-targeted cancer therapies bas...

August 5, 2019 | Monday | News
Sysmex gets Japanese manufacturing and marketing approval

Sysmex Corporation has obtained Japanese manufacturing and marketing approval for the OncoBEAM™ RAS CRC Kit, ...

August 2, 2019 | Friday | News
Morimoto Pharma unveils new Exposure Prevention Prefilled Syringe Kits

Japanese firm Morimoto Pharma has revealed their new prefilled syringe product, the Morimoto S.A.F.E. Syringe ...

August 5, 2019 | Monday | News
Fujifilm completes acquisition of Biogen's Manufacturing Site in Denmark

FUJIFILM Corporation has announced that it has completed the acquisition of Biogen (Denmark) Manufacturing ApS, a large-...

August 2, 2019 | Friday | News
Marken acquires PCX International to strengthen supply chain footprint

Marken, a US headquartered patient-centric supply chain organization, has announced  the acquisition of PCX Interna...

August 2, 2019 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls